Zepp Health Corporation
ZEPP News Today: Stay Updated with the Latest Zepp Health Corporation News in Real Time
Find ZEPP news now at Meyka AI. Stay informed with the latest Zepp Health Corporation stocks updates, including price news, market analysis, and expert insights.
India’s HPV Vaccination Drive: February 28 — Pharma Demand Watch
India’s hpv vaccination drive starts 28 Feb with a single-dose HPV vaccine for 14-year-old girls. See demand outlook for vaccines, diagnostics, cold chain, and hospitals.
5277.T Spancrete (JPX) pre-market 28 Feb 2026: JPY 452.00 oversold bounce setup
Pre-market note: 5277.T stock at JPY 452.00 shows oversold bounce signals with Meyka AI forecast and targets
Cowen Maintains Buy on Royalty Pharma plc (RPRX) Feb 27, 2026
Cowen keeps RPRX analyst rating at Buy and raises PT to $50 on Feb 27, 2026
Hong Kong Budget Surplus for 2025-26 as IPOs Revive — February 28
Hong Kong budget surplus returns for 2025-26 as IPOs revive and stock market turnover improves, lifting stamp duty revenue. See drivers, market impact, and what investors should watch next.
Pre-market 28 Feb 2026 JPX: 3076.T stock at JPY 2,923.00, AI boost possible
Pre-market update on 3076.T stock at JPY 2,923.00 on JPX; valuation, Meyka AI grade, and forecast to JPY 3,080.98
ATH.TO stock: Athabasca Oil (TSX) at C$8.90 ahead of Mar 4 earnings — what to watch
ATH.TO stock trades at C$8.90 ahead of Mar 4 earnings. Key metrics, Meyka AI grade and a 3-year forecast for ATH.TO stock
155,010-share spike at TripSitter Clinic Ltd (KETA.CN CNQ) 27 Feb 2026: monitor
KETA.CN stock sees **155,010** shares traded, price C$0.065 on 27 Feb 2026; volume spike signals short-term trade setup
DUOL Stock Today: February 27 — Growth Shift Sparks 20% Slide
Duolingo stock fell about 20% after DUOL earnings as management shifted to a user growth strategy and issued a softer bookings outlook. See key KPIs, risks, and what to watch next.
Earnings due 4 Mar: CSE Global (544.SI, SES) pre-market S$1.28, margin focus
544.SI stock pre-market at S$1.28 ahead of 4 Mar earnings; forecast S$1.49 and analyst angles for margins and cash flow